NASDAQ:ZIOP

ZIOPHARM Oncology News Headlines

$2.63
-0.05 (-1.87 %)
(As of 06/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.59
$2.73
50-Day Range
$2.63
$3.54
52-Week Range
$2.06
$5.95
Volume1.55 million shs
Average Volume2.35 million shs
Market Capitalization$566.83 million
P/E RatioN/A
Dividend YieldN/A
Beta2.07

ZIOPHARM Oncology (NASDAQ ZIOP) News Headlines Today

SourceHeadline
ZIOP Jun 2021 5.500 callZIOP Jun 2021 5.500 call
ca.finance.yahoo.com - June 18 at 10:44 PM
ZIOPHARM Oncology (NASDAQ:ZIOP)  Shares Down 7% ZIOPHARM Oncology (NASDAQ:ZIOP) Shares Down 7%
americanbankingnews.com - June 10 at 12:56 PM
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Receives Consensus Recommendation of "Hold" from BrokeragesZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Receives Consensus Recommendation of "Hold" from Brokerages
americanbankingnews.com - June 10 at 1:26 AM
ZIOPHARM Oncology (NASDAQ:ZIOP) Shares Gap Up to $2.93ZIOPHARM Oncology (NASDAQ:ZIOP) Shares Gap Up to $2.93
americanbankingnews.com - June 9 at 10:28 AM
Zacks: Brokerages Expect ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) to Post -$0.13 Earnings Per ShareZacks: Brokerages Expect ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) to Post -$0.13 Earnings Per Share
americanbankingnews.com - June 6 at 9:08 PM
Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders MeetingZiopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting
finance.yahoo.com - May 19 at 6:19 PM
What Type Of Shareholders Own The Most Number of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Shares?What Type Of Shareholders Own The Most Number of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Shares?
nasdaq.com - May 19 at 12:22 AM
ZIOPHARM Oncology, Inc. 2021 Q1 - Results - Earnings Call PresentationZIOPHARM Oncology, Inc. 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 7 at 5:04 PM
ZIOPHARM Oncology Q1 Earnings PreviewZIOPHARM Oncology Q1 Earnings Preview
seekingalpha.com - May 7 at 1:00 PM
Ziopharm Oncology Inc (ZIOP) Q1 2021 Earnings Call TranscriptZiopharm Oncology Inc (ZIOP) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 7 at 1:00 PM
Ziopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate UpdatesZiopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Updates
finance.yahoo.com - May 6 at 7:13 PM
Ziopharm Oncology Scientific Advisor Laurence Cooper, MD, PhD, to Present at University of Pennsylvania Cellicon Valley ’21 Two-Day Live Virtual Educational SymposiumZiopharm Oncology Scientific Advisor Laurence Cooper, MD, PhD, to Present at University of Pennsylvania Cellicon Valley ’21 Two-Day Live Virtual Educational Symposium
finance.yahoo.com - May 4 at 10:17 AM
Ziopharm Oncology to Report First Quarter Financial Results on May 6, 2021Ziopharm Oncology to Report First Quarter Financial Results on May 6, 2021
finance.yahoo.com - April 29 at 12:00 PM
Cedilla Therapeutics Appoints Chris Bowden, M.D. to its Board of DirectorsCedilla Therapeutics Appoints Chris Bowden, M.D. to its Board of Directors
ca.finance.yahoo.com - April 21 at 12:42 PM
Ziopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCellZiopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCell
finance.yahoo.com - April 19 at 8:24 AM
Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual MeetingZiopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting
finance.yahoo.com - April 7 at 1:30 PM
ZIOP Apr 2021 4.500 callZIOP Apr 2021 4.500 call
uk.finance.yahoo.com - April 4 at 8:46 AM
Why Ziopharm Oncology Stock Is Sinking TodayWhy Ziopharm Oncology Stock Is Sinking Today
finance.yahoo.com - March 20 at 3:17 AM
Ziopharm Oncology IncShs HoldZiopharm Oncology IncShs Hold
markets.businessinsider.com - March 14 at 8:57 AM
Why Ziopharm Oncology Stock Is Jumping TodayWhy Ziopharm Oncology Stock Is Jumping Today
finance.yahoo.com - February 26 at 1:44 PM
Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021
finance.yahoo.com - February 16 at 5:33 PM
Chronic Lymphocytic Leukemia Treatment Market Trends, Growth Outlook, Business Overview, Sales Insights and COVID-19 Impact Analysis By 2023Chronic Lymphocytic Leukemia Treatment Market Trends, Growth Outlook, Business Overview, Sales Insights and COVID-19 Impact Analysis By 2023
marketwatch.com - February 10 at 8:18 AM
Analyzing ZIOPHARM Oncologys Unusual Options ActivityAnalyzing ZIOPHARM Oncology's Unusual Options Activity
finance.yahoo.com - February 8 at 2:38 PM
Ziopharm Oncology Announces Election of Robert Postma to its Board of DirectorsZiopharm Oncology Announces Election of Robert Postma to its Board of Directors
markets.businessinsider.com - February 5 at 12:29 PM
Ziopharm to Participate in Upcoming January ConferencesZiopharm to Participate in Upcoming January Conferences
finance.yahoo.com - December 23 at 8:15 PM
Companies Like ZIOPHARM Oncology (NASDAQ:ZIOP) Are In A Position To Invest In GrowthCompanies Like ZIOPHARM Oncology (NASDAQ:ZIOP) Are In A Position To Invest In Growth
finance.yahoo.com - December 23 at 3:15 PM
Ziopharm Oncology Announces Clearance of Taiwans First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and LymphomasZiopharm Oncology Announces Clearance of Taiwan's First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and Lymphomas
marketwatch.com - December 22 at 10:33 PM
Ziopharm Oncology Announces Clearance of Taiwan’s First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and LymphomasZiopharm Oncology Announces Clearance of Taiwan’s First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and Lymphomas
finance.yahoo.com - December 21 at 8:06 PM
Are Options Traders Betting on a Big Move in Ziopharm (ZIOP) Stock?Are Options Traders Betting on a Big Move in Ziopharm (ZIOP) Stock?
finance.yahoo.com - December 17 at 10:15 AM
WaterMill Asset Management Issues Statement Regarding Consent Solicitation at Ziopharm OncologyWaterMill Asset Management Issues Statement Regarding Consent Solicitation at Ziopharm Oncology
finance.yahoo.com - December 17 at 10:15 AM
12 Health Care Stocks Moving In Wednesdays After-Market Session12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com - December 16 at 10:30 PM
Ziopharm Comments on Consent Solicitation ResultsZiopharm Comments on Consent Solicitation Results
finance.yahoo.com - December 16 at 5:30 PM
Ziopharm Oncology Announces Chief Financial Officer to Step DownZiopharm Oncology Announces Chief Financial Officer to Step Down
finance.yahoo.com - December 14 at 6:34 PM
WaterMill Asset Management Addresses Ziopharm Oncologys Latest Distortion and Recent ThreatWaterMill Asset Management Addresses Ziopharm Oncology's Latest Distortion and Recent Threat
benzinga.com - December 14 at 8:33 AM
Is ZIOP A Good Stock To Buy Now?Is ZIOP A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 8:33 AM
WaterMill Asset Management Addresses Ziopharm Oncology’s Latest Distortion and Recent ThreatWaterMill Asset Management Addresses Ziopharm Oncology’s Latest Distortion and Recent Threat
finance.yahoo.com - December 12 at 8:58 PM
Ziopharm Comments on Delay of WaterMill’s Stated Consent DeadlineZiopharm Comments on Delay of WaterMill’s Stated Consent Deadline
finance.yahoo.com - December 11 at 10:38 PM
Egan-Jones Recommends Against Electing Dissidents Full Slate of Nominees to Ziopharm BoardEgan-Jones Recommends Against Electing Dissident's Full Slate of Nominees to Ziopharm Board
benzinga.com - December 10 at 9:35 PM
Egan-Jones Recommends Against Electing Dissident’s Full Slate of Nominees to Ziopharm BoardEgan-Jones Recommends Against Electing Dissident’s Full Slate of Nominees to Ziopharm Board
finance.yahoo.com - December 10 at 9:35 PM
WaterMill Asset Management Reinforces the Need for Meaningful and Urgent Change at Ziopharm OncologyWaterMill Asset Management Reinforces the Need for Meaningful and Urgent Change at Ziopharm Oncology
finance.yahoo.com - December 8 at 1:50 PM
Ziopharm Details Actions in Response to Shareholder Feedback - MarketWatchZiopharm Details Actions in Response to Shareholder Feedback - MarketWatch
marketwatch.com - December 6 at 7:36 PM
Ziopharm Details Actions in Response to Shareholder FeedbackZiopharm Details Actions in Response to Shareholder Feedback
finance.yahoo.com - December 4 at 6:39 PM
Glass Lewis Recommends Ziopharm Shareholders Vote on the WHITE Consent Card for All of WaterMills Director Candidates and ProposalsGlass Lewis Recommends Ziopharm Shareholders Vote on the WHITE Consent Card for All of WaterMill's Director Candidates and Proposals
benzinga.com - December 3 at 2:03 AM
Glass Lewis Recommends Ziopharm Shareholders Vote on the WHITE Consent Card for All of WaterMill’s Director Candidates and ProposalsGlass Lewis Recommends Ziopharm Shareholders Vote on the WHITE Consent Card for All of WaterMill’s Director Candidates and Proposals
finance.yahoo.com - December 3 at 2:03 AM
Proxy firm Glass Lewis backs investor WaterMills board nominees at Ziopharm OncologyProxy firm Glass Lewis backs investor WaterMill's board nominees at Ziopharm Oncology
finance.yahoo.com - December 3 at 2:03 AM
WaterMill Asset Management Refutes Ziopharm Oncologys Desperate, Low-Road Smear CampaignWaterMill Asset Management Refutes Ziopharm Oncology's Desperate, Low-Road Smear Campaign
benzinga.com - November 30 at 8:46 PM
Ziopharm Comments on Institutional Shareholder Services’ Recommendation to Reject WaterMill’s Attempt to Remove Half of Ziopharm’s Board of DirectorsZiopharm Comments on Institutional Shareholder Services’ Recommendation to Reject WaterMill’s Attempt to Remove Half of Ziopharm’s Board of Directors
finance.yahoo.com - November 27 at 6:18 PM
ISS backs two of three of activists board nominees at Ziopharm OncologyISS backs two of three of activist's board nominees at Ziopharm Oncology
finance.yahoo.com - November 25 at 8:54 PM
ISS Recommends Ziopharm Shareholders Vote for Change on WaterMill Asset Management’s WHITE Consent CardISS Recommends Ziopharm Shareholders Vote for Change on WaterMill Asset Management’s WHITE Consent Card
finance.yahoo.com - November 25 at 8:54 PM
WaterMill Asset Management Sets the Record Straight Following Ziopharm’s Apparent Attempt to Mislead Shareholders and Rewrite HistoryWaterMill Asset Management Sets the Record Straight Following Ziopharm’s Apparent Attempt to Mislead Shareholders and Rewrite History
finance.yahoo.com - November 24 at 12:52 PM
This page was last updated on 6/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.